Related Experiment Videos
Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks
W Lockette1, S Ghosh, S Farrow
1Department of Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA.
American Journal of Hypertension
|April 1, 1995
Summary
Genetic variations in alpha 2-adrenergic receptors may contribute to hypertension in Black Americans. A specific gene polymorphism was more common in hypertensive Black individuals, suggesting a potential link to blood pressure regulation.
Area of Science:
- Pharmacology
- Genetics
- Cardiovascular Medicine
Background:
- Alpha 2-adrenergic receptors are widely distributed, influencing neuronal activity, blood pressure, and metabolic functions.
- Dysregulation of alpha 2-adrenergic receptors is a potential factor in hypertension, particularly its higher prevalence in Black populations.
Purpose of the Study:
- To investigate the association between alpha 2-adrenergic receptor gene polymorphism and hypertension in American Blacks.
- To determine if genetic variations in alpha 2-adrenergic receptors contribute to the elevated blood pressure observed in this demographic.
Main Methods:
- Utilized Dra-I restriction fragment-length polymorphism (RFLP) analysis to identify variations in the alpha 2-adrenergic receptor gene.
- Studied 227 individuals, including hypertensive and normotensive subjects, analyzing allele frequencies across racial groups.
Main Results:
- A 6.3-kb allele polymorphism of the alpha 2-adrenergic receptor gene was significantly more prevalent in hypertensive Black subjects (13/82) compared to normotensive Black subjects (2/59).
- No significant association was found in white subjects, suggesting ethnic-specific genetic influences.
- The overall association in all subjects was statistically significant (P = .008).
Conclusions:
- A genetic polymorphism in the alpha 2-adrenergic receptor gene on chromosome 10 may contribute to hypertension development in Black Americans.
- Ethnic variations in genetic factors likely play a role in the differential prevalence of hypertension.